United Kingdom · Question · Written question
UIN 169047
Phenylketonuria: Sapropterin
Introduced
15 March 2021
Last action
23 March 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
23 March 2021
Summary
To ask the Secretary of State for Health and Social Care, if he will make urgent representations to NICE to ensure that Sapropterin (Kuvan) can be made available for Phenylketonuria (a) on the basis of clinical need and (b) not restricted to people under
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
15 March 2021
Written question
To ask the Secretary of State for Health and Social Care, if he will make urgent representations to NICE to ensure that Sapropterin (Kuvan) can be made available for Phenylketonuria (a) on the basis of clinical need and (b) not restricted to people under
Source: Commons
23 March 2021
Answer
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing evidence-based guidance for the National Health Service on whether medicines represent a clinical and cost-effective use of resources. NICE is c...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-03-15/169047
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1302426
- uk · wq-1302426 · source updated 23 March 2021